Raia Drogasil revenue and financials
R$21.27Change from previous close: −0.09%Absolute change: −R$0.02
In the fiscal year ended December 2025, Raia Drogasil reported revenue of R$44.25B (+13.84% year over year). Net income was R$1.3B, a net margin of 2.9%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +13.84%
- 2025 vs 2024
- Net income growth
- +8.08%
- 2025 vs 2024
- Net margin
- 2.9%
- 2024: 3.1%
Financial data
Amounts in millions of BRL; per-share values in BRL; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 2,431 | 2,771 | 1,785 | 1,682 | 1,557 |
| Depreciation and amortization | 1,873 | 1,646 | 1,562 | 1,421 | 1,264 |
| Capital expenditure | -1,403 | -1,284 | -1,305 | -1,189 | -856 |
| Investing cash flow | -1,406 | -1,413 | -1,307 | -1,229 | -886 |
| Financing cash flow | -1,043 | -1,243 | -499 | -375 | -1,195 |
| Dividends paid | -653 | -475 | -466 | -324 | -265 |
| Share repurchases | -5.5 | -73.3 | 0.0 | 0.0 | -73.2 |
| Debt issued | 1,190 | 689 | 1,059 | 1,460 | — |
| Debt repaid | -654 | -525 | -270 | -668 | — |
| Net change in cash | -18.4 | 116 | -21.2 | 77.4 | -524 |
| Free cash flow | 1,028 | 1,488 | 481 | 493 | 701 |
| Levered free cash flow | 551 | 1,556 | 516 | 222 | 714 |
